In summary, these data support a model in which high expression of SOX2—as a consequence of copy number variation—but also other so-far less well characterized mechanisms contribute to the pathogenesis of HNSCC by promoting tumor cell proliferation and survival. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.